Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

25.0%

2 terminated out of 8 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

100%

5 of 5 completed with results

Key Signals

5 with results71% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (7)
P 4 (1)

Trial Status

Completed5
Terminated2
Unknown1

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (8)

Research Network

Activity Timeline